Health Canada — Medical Devices · Canada · 2022-06-07 · Type II
🏛Compiled from an official source — the facts on this page are reproduced from the issuing authority’s own published notice, which is linked above. No AI-generated text appears on this page. How we use AI →
Reported risk: Beckman coulter has discovered that affected Duraclone B27 Reagent Kits may exhibit reduced fluorescence intensity potentially leading to incorrect results. Consequently, Duraclone B27 may not conform to sensitivity and accuracy claim of 100% and 95% respectively as outlined in the product instructions for use (IFU). Recall start date: May 23, 2022
Verify each fact at the issuing agency before acting. Recall scope, affected lots, and remediation instructions may be updated by the agency after our last sync.
ProductGuru indexes recall and safety-alert records from ~30 public agency registries. We are not lawyers, regulators or product-safety consultants. This page restates what the named agency published; consult the primary source above (or qualified counsel in your jurisdiction) before any commercial, medical or safety decision.